Longwood Capital Partners »

Sutro Biopharma shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $780k 68k 11.57

More positions owned by Longwood Capital Partners

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I (PRAX)
Cidara Therapeutics Com New (CDTX)
Ocular Therapeutix (OCUL)
Aadi Bioscience (WHWK)
Bright Minds Biosciences Com New (DRUG)
Compass Therapeutics (CMPX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Insmed Com Par $.01 (INSM)
Argen Se - Sponsored Adr (ARGX)
Surrozen Com New (SRZN)
Amylyx Pharmaceuticals (AMLX)
Minerva Neurosciences Com New (NERV)
Tango Therapeutics (TNGX)
Taysha Gene Therapies Com Shs (TSHA)

View all positions for Longwood Capital Partners

Top funds holding Sutro Biopharma

Affinity Asset Advisors
Vanguard Group
Acadian Asset Management
Samsara BioCapital
Eversept Partners
Opaleye Management
Point72 Asset Management
Tang Capital Management
Renaissance Technologies
GSA Capital Partners
Marshall Wace
Geode Capital Management
Longwood Capital Partners
ADAR1 Capital Management
Fisher Investments

View all funds holding Sutro Biopharma